CLOV vs NDAQ · rev $1.37B vs P/E 41, rev $8.26B
Clover Health Investments Corp (CLOV) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported NDAQ revenue for 2025-12-31 was $8.26B. Net income was $1.79B. Revenue was up 11.6% from 2024-12-31 to 2025-12-31. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
CLOV currently screens at market cap $1.55B. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the CLOV and NDAQ stock pages for the full models.
Not investment advice.